3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
2
Terminated
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Ovarian Neoplasms
1
Metastatic Breast Cancer in Germline-PALB2 Mutations Carriers
1
Glioma
1
Efficacy
1
Advanced Ovarian Cancer
1
Interventions
Temozolomide
4
vorasidenib
2
Lomustine
2
Blood Specimen Collection
2
trametinib
1
tovorafenib
1
posaconazole
1
perillyl alcohol
1
pembrolizumab
1
niraparib
1
mirdametinib
1
gallium maltolate
1
dabrafenib
1
cemiplimab
1
Urination
1
Transurethral Resection of Bladder
1
Standard of Care
1
Spinal Puncture
1
Specimen Handling
1
Sitagliptin Phosphate
1
Receptors, Interleukin-8B
1
Radiotherapy
1
Radiation
1
Positron Emission Tomography Computed Tomography
1
Physical Therapy Modalities
1
Mental Status and Dementia Tests
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Ketoconazole
1
Histocompatibility Testing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Glioma
×
niraparib
×
Clear all
NCT06258018
2024-08-30
ONC-2022-001
Istituto Clinico Humanitas
Phase 1/2
Not yet recruiting
86 enrolled